Navigation Links
Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin
Date:8/16/2011

200 mg twice daily) or oral vancomycin (125 mg four times daily) for 10 days. If patients achieved clinical cure, they were followed for recurrence for 4 weeks. Patients were considered to have taken concomitant antibiotics if they received one or more oral or IV doses of antibiotics during the treatment or follow-up periods.  Eligible patients had received a diagnosis of first episode of CDAD or a first recurrence of CDAD within the previous three months and had received no more than 24 hours of pretreatment with vancomycin or metronidazole. Treatment with other therapies potentially effective for CDAD, such as oral bacitracin, fusidic acid and rifaximin were not allowed. Topical antibiotics, treatments for CDAD and antifungal and antiviral agents with no antibacterial activity were not included as concomitant antibiotics. Patients were excluded if diagnosed with immediately life-threatening CDAD.

Clinical cure was defined as resolution of diarrhea (less than or equal to three unformed stools for two consecutive days) maintained until the end of therapy and for two days afterward. Recurrence was defined as the reappearance of symptoms of CDAD within four weeks after completing treatment, the presence of C. difficile toxin A, toxin B, or both in stool, and the need for retreatment.  Global cure was defined as clinical cure with no recurrence during the follow-up period.

About CDAD

Clostridium difficile-associated diarrhea (CDAD) has become a significant medical problem in hospitals, long-term care facilities and in the community. CDAD is a serious illness resulting from infection of the inner lining of the colon by C. difficile bacteria, which produce toxins that cause inflammation of the colon, severe diarrhea and, in the most serious cases, death. Patients typically develop CDAD from the use of broad-spectrum antibiotics that disrupt normal gastrointestinal (gut) flora, possibly allowing C. difficile'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... 26, 2015  OncoGenex Pharmaceuticals, Inc. (NASDAQ: ... developments and announced fourth quarter and year end ... and Anticipated Near-term MilestonesCustirsen , Collaboration: ... negotiate the termination of their collaboration and return ... termination agreement are ongoing. , Two Phase ...
(Date:3/26/2015)... March 26, 2015 When they began ... existing PACS vendor their system would no longer ... they needed a better structured solution to support ... interWORKS due to its interface capabilities and its ... standards through to the hospital,s radiology department. Avreo,s ...
(Date:3/26/2015)... , March 26, 2015 A ... optimism that comparative effectiveness research (CER) will yield ... not yet seeing the impact of CER in ... fifth annual survey of stakeholders shows that they ... an impact on health care and decision-making in ...
Breaking Medicine Technology:OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 2OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 3OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 4OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 5OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 6OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 7OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 8Clinch Memorial Hospital Modernizes Workflow with Avreo interWORKS 2NPC Highlights Stakeholder Views on Comparative Effectiveness Research and the Environment for Health Care Decision-Making 2NPC Highlights Stakeholder Views on Comparative Effectiveness Research and the Environment for Health Care Decision-Making 3NPC Highlights Stakeholder Views on Comparative Effectiveness Research and the Environment for Health Care Decision-Making 4
(Date:3/26/2015)... March 26, 2015 The National ... Assessment and Evaluation , has announced its partnership ... institutions, organizations, and corporations to accurately and securely ... learning. , Utilizing Questionmark’s state-of-the-art software and ... will offer improved delivery of the seventy-five to ...
(Date:3/26/2015)... 26, 2015 Volunteers will collectively walk ... Parkinson’s disease and funds to support the American ... Burden – Find the Cure. The Optimism ... place in more than 20 locations including, Boston, Chicago, ... San Antonio, Minnesota, Seattle, St. Louis, New York, Nevada, ...
(Date:3/26/2015)... Leading nutritional supplement provider Metabolic Nutrition ... http://www.metabolicnutrition.com . The ultramodern, clean and unique ... experience for consumers seeking information about the highly-regarded ... Metabolic Nutrition website includes: , , ... of products, conveniently broken down by user goals ...
(Date:3/26/2015)... Silver Spring, Md. (PRWEB) March 26, 2015 ... of participating in a pageant. Not until last year, ... Lyndsi’s daughter Eliana has pulmonary hypertension (PH) – a ... of the heart and can lead to right-heart failure. ... Eliana was born in 2003. Lyndsi entered the pageant ...
(Date:3/26/2015)... 2015 Upcoming live shows will feature many ... on the year that Creedence Clearwater Revival had a great ... will be available March 26, and U.S. fans will want ... quickly as they can. , Visit QueenBeeTickets.com ... prices. , The tour will be hitting a variety of ...
Breaking Medicine News(10 mins):Health News:NLN Testing Services Announces Improved Delivery and Analytics Software and Newly Developed and Revised Exams 2Health News:American Parkinson Disease Association 2015 Optimism Walk Season Launches Nationwide 2Health News:Metabolic Nutrition Launches Sleek New Website with New Features and Enhanced Consumer Information 2Health News:Albuquerque Area Mom Enters Mrs. New Mexico Pageant to Help Fight Pulmonary Hypertension 2Health News:John Fogerty Presale Tickets: QueenBeeTickets.com Reduces Prices on John Fogerty Concert Tickets During Presales for Expanded “1969” Tour Dates 2
... than 300 Join to Discuss Health Game Trends and Developments at Boston ... , BOSTON , June 11 Beginning today, the Games for ... 5th annual Games for Health Conference at the Boston Hyatt Harborside. Having ... days will bring together several hundred of the sharpest minds in the ...
... Denmark, Thursday 11 June 2009: Undertaking a supervised ... status and physical function, reduce the need for ... of depression and anxiety in people with rheumatoid ... today at EULAR 2009, the Annual Congress of ...
... SeprOx Corporation received a pre-seed ... by Governor Rick Perry at Texas Technology Leadership Day held ... receive an initial investment of $250,000 and is eligible to ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20090611/DA30680LOGO ) , , "Too ...
... Wellness Efforts , , LOS ANGELES, June 11 ... Conference in Los Angeles highlights the need for a comprehensive ... childhood obesity. More than 15 million children are obese ... 2 diabetes rates and more than $14 billion in health ...
... August Luncheon , , DENVER, June 11 DaVita ... kidney care services for those diagnosed with chronic kidney disease ... Los Angeles Business Journal ,s 2009 "Best Places to ... companies chosen for their impact on the region,s economy, its ...
... most relevant information, study shows , THURSDAY, June 11 (HealthDay ... sleeping brain seems to store only the most useful information, ... 44 college students aged 18 to 22, the study findings ... of learning, sleep can preserve the most important memories for ...
Cached Medicine News:Health News:Fifth Annual Games for Health Conference Kicks Off in Boston 2Health News:Fifth Annual Games for Health Conference Kicks Off in Boston 3Health News:Fifth Annual Games for Health Conference Kicks Off in Boston 4Health News:Exercise improves functional and psycological ability and reduces steroid need in rheumatoid arthritis 2Health News:SeprOx Receives Texas Emerging Technology Fund Award 2Health News:Kaiser Permanente Calls for Health Policy Support and Community Advocacy to Curb Childhood Obesity 2Health News:Kaiser Permanente Calls for Health Policy Support and Community Advocacy to Curb Childhood Obesity 3Health News:DaVita Named to List of 'Best Places to Work in Los Angeles' by the Los Angeles Business Journal 2
... Electronic Medical Records (including ExamDRAW) is the ... in the industry. Doctors and staff can ... speed and accuracy using our trademarked pre-written ... for typing, we have created the fastest, ...
... Revolution™ represents the latest in advanced ... universal mixer quickly mixes and mechanically injects ... conveniently. , ,The Revolution&trade line-up includes ... placement of cement, even in difficult to ...
... ULTRAMIX Vacuum Mixing System to make the ... optimum strength. , ,The ULTRAMIX Vacuum ... that protects the user from monomer fumes ... The unique offset paddle design creates a ...
... with Tobramycin is the original ... with the addition of 1g ... original formula, surgeons can expect ... Simplex™ P Bone Cement, while ...
Medicine Products: